ABN AMRO Investment Solutions’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7M Buy
37,024
+6,774
+22% +$2.96M 0.13% 114
2026
Q1
$13.9M Buy
30,250
+5,094
+20% +$2.58M 0.18% 107
2025
Q4
$14.2M Buy
25,156
+15,429
+159% +$8.21M 0.21% 91
2025
Q3
$4.35M Sell
9,727
-9,336
-49% -$4.48M 0.09% 171
2025
Q2
$10.4M Sell
19,063
-4,718
-20% -$2.47M 0.21% 91
2025
Q1
$11.8M Sell
23,781
-2,099
-8% -$1.16M 0.25% 87
2024
Q4
$13.5M Buy
25,880
+444
+2% +$231K 0.25% 81
2024
Q3
$12.5M Sell
25,436
-1,373
-5% -$639K 0.22% 90
2024
Q2
$11.9M Buy
26,809
+4,762
+22% +$1.9M 0.22% 93
2024
Q1
$8.8M Sell
22,047
-1,471
-6% -$556K 0.15% 114
2023
Q4
$7.93M Buy
23,518
+2,855
+14% +$851K 0.14% 128
2023
Q3
$6.04M Buy
20,663
+6,010
+41% +$1.88M 0.12% 150
2023
Q2
$5.01M Sell
14,653
-471
-3% -$143K 0.1% 159
2023
Q1
$3.86M Buy
+15,124
New +$3.73M 0.08% 187

Other funds holding ISRG

ABN AMRO Investment Solutions's ISRG Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Intuitive Surgical (ISRG) stake by 22% in Q2 2026, buying an estimated $2.96M and bringing the position to 37,024 shares worth $14.7M. The position accounts for 0.13% of the portfolio, ranked #114.

ABN AMRO Investment Solutions first reported a position in ISRG in Q1 2023 and has held it in 14 quarters since. 2,234 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • ABN AMRO Investment Solutions held 37,024 shares of Intuitive Surgical worth $14.7M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 6,774 Intuitive Surgical shares in Q2 2026, an estimated $2.96M.
  • Intuitive Surgical made up 0.13% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #114 holding.
  • ABN AMRO Investment Solutions first reported a position in Intuitive Surgical in Q1 2023 and has held it in 14 quarters since.
  • 2,234 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.